0 XP   0   0   0

Core Laboratories NV










Financial Health of Core Laboratories NV




Comparing to competitors in the Oil & Gas Equipment & Services industry




  Industry Rankings  


Richest
#97 / 204

Total Sales
#68 / 204

Making Money
#57 / 204

Working Efficiently
#69 / 204

Core Laboratories NV
Buy, Hold or Sell?

Should you buy, hold or sell Core Laboratories NV?

I guess you are interested in Core Laboratories NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Core Laboratories NV

Let's start. I'm going to help you getting a better view of Core Laboratories NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Core Laboratories NV even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Core Laboratories NV is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Core Laboratories NV. The closing price on 2022-12-01 was €20.80 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Core Laboratories NV Daily Candlestick Chart

Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

1.1. Profitability of Core Laboratories NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Core Laboratories NV earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • A Net Profit Margin of 6.0% means that €0.06 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Core Laboratories NV:

  • The MRQ is 6.0%. The company is making a profit. +1
  • The TTM is 3.1%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.0%TTM3.1%+2.9%
TTM3.1%YOY6.7%-3.6%
TTM3.1%5Y4.2%-1.1%
5Y4.2%10Y5.3%-1.1%
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0%1.8%+4.2%
TTM3.1%0.8%+2.3%
YOY6.7%-4.5%+11.2%
5Y4.2%-5.5%+9.7%
10Y5.3%-3.1%+8.4%
1.1.2. Return on Assets

Shows how efficient Core Laboratories NV is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • 1.3% Return on Assets means that Core Laboratories NV generated €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Core Laboratories NV:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.3%TTM0.7%+0.6%
TTM0.7%YOY1.3%-0.6%
TTM0.7%5Y1.0%-0.3%
5Y1.0%10Y1.3%-0.3%
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%0.6%+0.7%
TTM0.7%0.3%+0.4%
YOY1.3%-0.4%+1.7%
5Y1.0%-0.7%+1.7%
10Y1.3%-0.2%+1.5%
1.1.3. Return on Equity

Shows how efficient Core Laboratories NV is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • 4.1% Return on Equity means Core Laboratories NV generated €0.04 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Core Laboratories NV:

  • The MRQ is 4.1%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.1%TTM2.2%+1.9%
TTM2.2%YOY7.3%-5.1%
TTM2.2%5Y-0.5%+2.7%
5Y-0.5%10Y1.4%-1.9%
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1%1.5%+2.6%
TTM2.2%0.6%+1.6%
YOY7.3%-0.4%+7.7%
5Y-0.5%-1.3%+0.8%
10Y1.4%-0.7%+2.1%

1.2. Operating Efficiency of Core Laboratories NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Core Laboratories NV is operating .

  • Measures how much profit Core Laboratories NV makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • An Operating Margin of 10.5% means the company generated €0.10  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Core Laboratories NV:

  • The MRQ is 10.5%. The company is operating less efficient.
  • The TTM is 8.2%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ10.5%TTM8.2%+2.2%
TTM8.2%YOY11.4%-3.2%
TTM8.2%5Y9.5%-1.3%
5Y9.5%10Y10.4%-0.9%
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ10.5%4.1%+6.4%
TTM8.2%2.6%+5.6%
YOY11.4%-2.5%+13.9%
5Y9.5%-2.1%+11.6%
10Y10.4%-1.5%+11.9%
1.2.2. Operating Ratio

Measures how efficient Core Laboratories NV is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Oil & Gas Equipment & Services industry mean).
  • An Operation Ratio of 1.70 means that the operating costs are €1.70 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Core Laboratories NV:

  • The MRQ is 1.702. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.757. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.702TTM1.757-0.055
TTM1.757YOY1.712+0.045
TTM1.7575Y1.652+0.105
5Y1.65210Y1.603+0.049
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7021.401+0.301
TTM1.7571.335+0.422
YOY1.7121.322+0.390
5Y1.6521.188+0.464
10Y1.6031.077+0.526

1.3. Liquidity of Core Laboratories NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Core Laboratories NV is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Oil & Gas Equipment & Services industry mean).
  • A Current Ratio of 2.23 means the company has €2.23 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Core Laboratories NV:

  • The MRQ is 2.235. The company is able to pay all its short-term debts. +1
  • The TTM is 2.106. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.235TTM2.106+0.128
TTM2.106YOY2.062+0.044
TTM2.1065Y2.003+0.104
5Y2.00310Y2.006-0.003
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2351.558+0.677
TTM2.1061.635+0.471
YOY2.0621.717+0.345
5Y2.0031.751+0.252
10Y2.0061.744+0.262
1.3.2. Quick Ratio

Measures if Core Laboratories NV is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • A Quick Ratio of 1.25 means the company can pay off €1.25 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Core Laboratories NV:

  • The MRQ is 1.253. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.182. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.253TTM1.182+0.071
TTM1.182YOY1.144+0.039
TTM1.1825Y1.220-0.038
5Y1.22010Y1.238-0.017
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2530.921+0.332
TTM1.1820.941+0.241
YOY1.1441.018+0.126
5Y1.2201.030+0.190
10Y1.2381.007+0.231

1.4. Solvency of Core Laboratories NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Core Laboratories NV assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Core Laboratories NV to Oil & Gas Equipment & Services industry mean.
  • A Debt to Asset Ratio of 0.68 means that Core Laboratories NV assets are financed with 67.9% credit (debt) and the remaining percentage (100% - 67.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Core Laboratories NV:

  • The MRQ is 0.679. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.704. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.679TTM0.704-0.025
TTM0.704YOY0.771-0.067
TTM0.7045Y0.768-0.064
5Y0.76810Y0.765+0.004
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6790.541+0.138
TTM0.7040.533+0.171
YOY0.7710.524+0.247
5Y0.7680.490+0.278
10Y0.7650.481+0.284
1.4.2. Debt to Equity Ratio

Measures if Core Laboratories NV is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • A Debt to Equity ratio of 211.1% means that company has €2.11 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Core Laboratories NV:

  • The MRQ is 2.111. The company is just not able to pay all its debts with equity.
  • The TTM is 2.389. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.111TTM2.389-0.279
TTM2.389YOY3.761-1.372
TTM2.3895Y3.911-1.521
5Y3.91110Y3.778+0.132
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1111.000+1.111
TTM2.3890.994+1.395
YOY3.7610.973+2.788
5Y3.9111.026+2.885
10Y3.7780.954+2.824

2. Market Valuation of Core Laboratories NV

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Core Laboratories NV generates.

  • Above 15 is considered overpriced but always compare Core Laboratories NV to the Oil & Gas Equipment & Services industry mean.
  • A PE ratio of 92.81 means the investor is paying €92.81 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Core Laboratories NV:

  • The EOD is 134.997. Seems overpriced? -1
  • The MRQ is 92.810. Neutral. Compare to industry.
  • The TTM is -39.984. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD134.997MRQ92.810+42.186
MRQ92.810TTM-39.984+132.794
TTM-39.984YOY434.590-474.574
TTM-39.9845Y159.982-199.965
5Y159.98210Y169.510-9.528
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
EOD134.99719.961+115.036
MRQ92.81020.354+72.456
TTM-39.9846.376-46.360
YOY434.590-1.725+436.315
5Y159.9829.958+150.024
10Y169.51010.455+159.055
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Core Laboratories NV.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Core Laboratories NV:

  • The MRQ is 1,524.681. Seems overpriced? -1
  • The TTM is 620.516. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ1,524.681TTM620.516+904.166
TTM620.516YOY-9,130.738+9,751.254
TTM620.5165Y-1,459.850+2,080.366
5Y-1,459.85010Y-1,329.686-130.164
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
MRQ1,524.6810.111+1,524.570
TTM620.5160.043+620.473
YOY-9,130.7380.010-9,130.748
5Y-1,459.8500.078-1,459.928
10Y-1,329.6860.054-1,329.740

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Core Laboratories NV is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Oil & Gas Equipment & Services industry mean).
  • A PB ratio of 3.81 means the investor is paying €3.81 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Core Laboratories NV:

  • The EOD is 5.541. Seems overpriced? -1
  • The MRQ is 3.810. Neutral. Compare to industry.
  • The TTM is 5.926. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD5.541MRQ3.810+1.732
MRQ3.810TTM5.926-2.116
TTM5.926YOY9.903-3.977
TTM5.9265Y14.080-8.154
5Y14.08010Y16.286-2.205
Compared to industry (Oil & Gas Equipment & Services)
PeriodCompanyIndustry (mean)+/- 
EOD5.5411.118+4.423
MRQ3.8101.123+2.687
TTM5.9261.048+4.878
YOY9.9030.812+9.091
5Y14.0800.868+13.212
10Y16.2860.792+15.494
2. Total Gains per Share

2.4. Latest News of Core Laboratories NV

Does Core Laboratories NV still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Core Laboratories NV to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-11-25
17:31
Core Laboratories (CLB) Up 9.6% Since Last Earnings Report: Can It Continue?Read
2022-11-05
15:56
Core Laboratories' (NYSE:CLB) earnings have declined over five years, contributing to shareholders 79% lossRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Core Laboratories NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1950.114+71%0.457-57%0.048+307%0.163+20%
Book Value Growth--0.002-0.019+971%0.113-98%-0.092+4261%-0.089+4158%
Book Value Per Share--3.7543.504+7%2.749+37%2.956+27%2.964+27%
Book Value Per Share Growth--0.0520.032+64%0.157-67%-0.032+161%-0.035+166%
Current Ratio--2.2352.106+6%2.062+8%2.003+12%2.006+11%
Debt To Asset Ratio--0.6790.704-4%0.771-12%0.768-12%0.765-11%
Debt To Equity Ratio--2.1112.389-12%3.761-44%3.911-46%3.778-44%
Dividend Per Share--0.0090.009+0%0.009+2%0.377-97%0.391-98%
Dividend Per Share Growth---0.0000%0.010-100%-1.5270%-1.3960%
Eps--0.1540.079+96%0.157-2%0.133+16%0.169-9%
Eps Growth--0.061-0.105+273%-2.029+3433%0.434-86%0.394-85%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin--0.0600.031+94%0.067-11%0.042+42%0.053+13%
Operating Margin--0.1050.082+27%0.114-8%0.095+10%0.104+1%
Operating Ratio--1.7021.757-3%1.712-1%1.652+3%1.603+6%
Pb Ratio5.541+31%3.8105.926-36%9.903-62%14.080-73%16.286-77%
Pe Ratio134.997+31%92.810-39.984+143%434.590-79%159.982-42%169.510-45%
Peg Ratio--1524.681620.516+146%-9130.738+699%-1459.850+196%-1329.686+187%
Price Per Share20.800+31%14.30020.550-30%25.625-44%42.006-66%48.750-71%
Price To Total Gains Ratio101.683+31%69.907658.913-89%151.557-54%206.676-66%216.189-68%
Profit Growth--1.157-13.698+1284%-218.819+19016%41.743-97%37.895-97%
Quick Ratio--1.2531.182+6%1.144+10%1.220+3%1.238+1%
Return On Assets--0.0130.007+97%0.013+0%0.010+31%0.013-1%
Return On Equity--0.0410.022+89%0.073-44%-0.005+112%0.014+202%
Revenue Growth---0.010-0.037+266%-0.025+145%-0.071+597%-0.069+581%
Total Gains Per Share--0.2050.124+66%0.467-56%0.425-52%0.554-63%
Total Gains Per Share Growth--0.215-3.373+1671%-1.929+998%0.421-49%-0.053+125%
Usd Book Value--183192922.022171018322.985+7%134170952.640+37%147173149.562+24%148405669.068+23%
Usd Book Value Change Per Share--0.2050.120+71%0.481-57%0.050+307%0.172+20%
Usd Book Value Per Share--3.9513.688+7%2.893+37%3.111+27%3.120+27%
Usd Dividend Per Share--0.0100.010+0%0.010+2%0.397-97%0.411-98%
Usd Eps--0.1620.083+96%0.165-2%0.140+16%0.178-9%
Usd Price Per Share21.892+31%15.05121.629-30%26.970-44%44.211-66%51.309-71%
Usd Profit--7519891.8963845399.265+96%7639826.376-2%6895832.818+9%8759017.974-14%
Usd Revenue--125897222.564121759233.141+3%114652865.337+10%142951455.866-12%146251527.020-14%
Usd Total Gains Per Share--0.2150.130+66%0.491-56%0.447-52%0.583-63%
 EOD+2 -3MRQTTM+30 -4YOY+19 -165Y+22 -1210Y+19 -15

3.2. Fundamental Score

Let's check the fundamental score of Core Laboratories NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15134.997
Price to Book Ratio (EOD)Between0-15.541
Net Profit Margin (MRQ)Greater than00.060
Operating Margin (MRQ)Greater than00.105
Quick Ratio (MRQ)Greater than11.253
Current Ratio (MRQ)Greater than12.235
Debt to Asset Ratio (MRQ)Less than10.679
Debt to Equity Ratio (MRQ)Less than12.111
Return on Equity (MRQ)Greater than0.150.041
Return on Assets (MRQ)Greater than0.050.013
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Core Laboratories NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose20.200
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets570,190
Total Liabilities386,897
Total Stockholder Equity183,293
 As reported
Total Liabilities 386,897
Total Stockholder Equity+ 183,293
Total Assets = 570,190

Assets

Total Assets570,190
Total Current Assets195,215
Long-term Assets195,215
Total Current Assets
Cash And Cash Equivalents 13,732
Net Receivables 109,493
Inventory 54,795
Other Current Assets 5,681
Total Current Assets  (as reported)195,215
Total Current Assets  (calculated)183,701
+/- 11,514
Long-term Assets
Property Plant Equipment 163,841
Goodwill 99,445
Intangible Assets 7,651
Other Assets 104,038
Long-term Assets  (as reported)374,975
Long-term Assets  (calculated)374,975
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities87,359
Long-term Liabilities299,538
Total Stockholder Equity183,293
Total Current Liabilities
Accounts payable 34,343
Other Current Liabilities 15,693
Total Current Liabilities  (as reported)87,359
Total Current Liabilities  (calculated)50,036
+/- 37,323
Long-term Liabilities
Long term Debt 182,677
Capital Lease Obligations Min Short Term Debt53,447
Other Liabilities 74,886
Long-term Liabilities Other 74,886
Long-term Liabilities  (as reported)299,538
Long-term Liabilities  (calculated)385,896
+/- 86,358
Total Stockholder Equity
Common Stock1,188
Retained Earnings 79,662
Total Stockholder Equity (as reported)183,293
Total Stockholder Equity (calculated)80,850
+/- 102,443
Other
Capital Stock1,188
Common Stock Shares Outstanding 46,325
Net Debt 168,945
Net Invested Capital 182,677
Net Tangible Assets 71,440
Net Working Capital 107,856



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
580,416
583,758
582,744
584,812
597,140
604,744
666,597
648,827
791,760
781,518
787,696
774,673
646,609
614,441
590,814
568,579
584,446
598,425
586,279
580,853
584,918
577,540
570,190
570,190577,540584,918580,853586,279598,425584,446568,579590,814614,441646,609774,673787,696781,518791,760648,827666,597604,744597,140584,812582,744583,758580,416
   > Total Current Assets 
200,981
206,222
203,129
207,427
220,185
225,662
239,125
230,977
236,423
225,233
230,686
221,237
219,707
191,393
169,889
165,848
185,817
201,149
187,245
189,055
202,192
199,621
195,215
195,215199,621202,192189,055187,245201,149185,817165,848169,889191,393219,707221,237230,686225,233236,423230,977239,125225,662220,185207,427203,129206,222200,981
       Cash And Cash Equivalents 
14,342
14,318
13,780
14,400
13,244
13,021
14,100
13,116
13,206
12,546
13,128
11,092
13,890
20,958
15,146
13,806
27,806
33,617
19,050
17,703
22,037
16,148
13,732
13,73216,14822,03717,70319,05033,61727,80613,80615,14620,95813,89011,09213,12812,54613,20613,11614,10013,02113,24414,40013,78014,31814,342
       Net Receivables 
130,548
138,050
138,457
140,605
146,444
148,047
152,386
143,150
132,859
134,900
137,355
138,106
132,771
109,998
93,457
92,867
99,941
110,168
107,770
106,741
113,540
111,499
109,493
109,493111,499113,540106,741107,770110,16899,94192,86793,457109,998132,771138,106137,355134,900132,859143,150152,386148,047146,444140,605138,457138,050130,548
       Inventory 
37,537
35,598
34,499
33,317
36,438
39,855
47,215
45,664
50,147
49,311
53,528
50,163
52,263
41,528
42,908
38,151
39,117
38,946
44,056
45,443
48,224
52,551
54,795
54,79552,55148,22445,44344,05638,94639,11738,15142,90841,52852,26350,16353,52849,31150,14745,66447,21539,85536,43833,31734,49935,59837,537
       Other Current Assets 
18,554
6,903
6,374
6,513
9,909
10,772
12,116
13,696
13,261
7,071
6,314
5,925
6,455
6,292
6,060
6,227
5,846
6,187
5,347
5,109
4,780
5,171
5,681
5,6815,1714,7805,1095,3476,1875,8466,2276,0606,2926,4555,9256,3147,07113,26113,69612,11610,7729,9096,5136,3746,90318,554
   > Long-term Assets 
0
0
0
0
0
0
0
0
555,337
556,285
557,010
553,436
426,902
423,048
420,925
402,731
398,629
397,276
399,034
391,798
382,726
377,919
374,975
374,975377,919382,726391,798399,034397,276398,629402,731420,925423,048426,902553,436557,010556,285555,33700000000
       Property Plant Equipment 
127,728
125,746
124,120
123,098
122,333
122,787
121,945
122,917
202,295
201,989
201,316
199,203
198,055
190,013
186,351
181,678
183,786
178,880
178,115
172,339
170,094
167,140
163,841
163,841167,140170,094172,339178,115178,880183,786181,678186,351190,013198,055199,203201,316201,989202,295122,917121,945122,787122,333123,098124,120125,746127,728
       Goodwill 
179,044
179,044
179,044
179,044
179,044
178,129
222,876
219,412
219,139
214,360
213,425
213,425
99,376
99,445
99,445
99,445
99,445
99,445
99,445
99,445
99,445
99,445
99,445
99,44599,44599,44599,44599,44599,44599,44599,44599,44599,44599,376213,425213,425214,360219,139219,412222,876178,129179,044179,044179,044179,044179,044
       Long Term Investments 
0
0
0
3,557
288
549
757
3,895
78
0
0
3,969
0
0
0
4,094
0
0
0
4,156
0
0
0
0004,1560004,0940003,96900783,8957575492883,557000
       Intangible Assets 
9,813
9,705
9,533
9,396
9,221
9,786
9,724
13,054
12,887
17,083
17,763
17,450
8,973
8,743
8,651
8,583
8,423
8,317
8,246
8,139
7,979
7,837
7,651
7,6517,8377,9798,1398,2468,3178,4238,5838,6518,7438,97317,45017,76317,08312,88713,0549,7249,7869,2219,3969,5339,7059,813
       Long-term Assets Other 
0
0
0
0
0
0
0
0
56,359
56,492
53,210
52,077
49,279
53,042
51,539
36,156
39,009
40,551
40,310
37,257
37,510
34,579
33,386
33,38634,57937,51037,25740,31040,55139,00936,15651,53953,04249,27952,07753,21056,49256,35900000000
> Total Liabilities 
431,009
432,306
429,447
436,080
445,564
446,970
505,185
487,927
604,407
593,257
597,450
596,808
580,893
552,338
519,105
493,006
438,400
444,081
425,265
419,852
418,532
403,773
386,897
386,897403,773418,532419,852425,265444,081438,400493,006519,105552,338580,893596,808597,450593,257604,407487,927505,185446,970445,564436,080429,447432,306431,009
   > Total Current Liabilities 
108,797
100,806
93,138
105,018
104,327
100,591
103,509
102,547
128,615
124,826
119,997
111,594
108,447
99,284
172,136
89,750
85,533
90,854
92,953
90,782
99,762
95,909
87,359
87,35995,90999,76290,78292,95390,85485,53389,750172,13699,284108,447111,594119,997124,826128,615102,547103,509100,591104,327105,01893,138100,806108,797
       Short-term Debt 
219,411
234,675
234,735
227,411
235,114
241,687
0
0
13,003
12,968
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000012,96813,00300241,687235,114227,411234,735234,675219,411
       Short Long Term Debt 
219,411
234,675
234,735
227,411
235,114
241,687
0
0
13,003
12,968
0
0
0
0
75,000
0
0
0
0
0
0
0
0
0000000075,000000012,96813,00300241,687235,114227,411234,735234,675219,411
       Accounts payable 
79,268
41,607
34,904
41,697
45,541
45,278
41,012
41,155
44,467
41,995
42,191
35,611
37,054
23,693
22,806
23,028
25,500
30,383
35,015
29,726
34,405
36,106
34,343
34,34336,10634,40529,72635,01530,38325,50023,02822,80623,69337,05435,61142,19141,99544,46741,15541,01245,27845,54141,69734,90441,60779,268
       Other Current Liabilities 
29,529
29,064
25,383
27,121
24,894
26,900
29,918
31,355
10,550
15,039
12,766
29,087
23,390
22,092
22,488
22,203
20,116
20,614
18,402
21,950
21,428
17,512
15,693
15,69317,51221,42821,95018,40220,61420,11622,20322,48822,09223,39029,08712,76615,03910,55031,35529,91826,90024,89427,12125,38329,06429,529
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
475,792
464,200
473,138
480,939
468,088
449,010
346,969
403,256
352,867
353,227
332,312
329,070
318,770
307,864
299,538
299,538307,864318,770329,070332,312353,227352,867403,256346,969449,010468,088480,939473,138464,200475,79200000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
290,022
297,148
305,283
302,420
286,610
0
0
0
0
0
0
0
0
0
000000000286,610302,420305,283297,148290,022000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
77,093
75,705
75,623
76,501
72,745
69,477
68,456
67,545
70,992
67,271
66,022
61,628
59,552
57,239
53,447
53,44757,23959,55261,62866,02267,27170,99267,54568,45669,47772,74576,50175,62375,70577,09300000000
       Other Liabilities 
44,454
96,825
101,574
103,651
106,123
104,692
105,931
95,540
116,372
110,359
110,877
109,942
103,158
102,505
98,439
85,224
83,680
84,401
85,181
85,702
80,591
76,654
74,886
74,88676,65480,59185,70285,18184,40183,68085,22498,439102,505103,158109,942110,877110,359116,37295,540105,931104,692106,123103,651101,57496,82544,454
> Total Stockholder Equity
149,407
147,493
149,371
144,844
147,638
153,783
157,438
156,759
183,165
188,261
190,246
177,865
65,716
62,103
67,632
75,573
146,046
154,344
161,014
161,001
166,386
173,767
183,293
183,293173,767166,386161,001161,014154,344146,04675,57367,63262,10365,716177,865190,246188,261183,165156,759157,438153,783147,638144,844149,371147,493149,407
   Common Stock
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,148
1,188
1,188
1,188
1,188
1,188
1,188
1,188
1,1881,1881,1881,1881,1881,1881,1881,1481,1481,1481,1481,1481,1481,1481,1481,1481,1481,1481,1481,1481,1481,1481,148
   Retained Earnings 
181,247
179,631
176,446
173,855
173,060
173,499
171,617
156,130
172,266
175,285
174,615
160,539
41,007
34,846
37,364
50,456
58,115
65,712
66,123
68,349
65,998
72,601
79,662
79,66272,60165,99868,34966,12365,71258,11550,45637,36434,84641,007160,539174,615175,285172,266156,130171,617173,499173,060173,855176,446179,631181,247
   Capital Surplus 
0
0
0
0
0
0
0
0
0
64,064
64,498
51,872
60,982
60,901
0
0
0
0
0
0
0
0
0
00000000060,90160,98251,87264,49864,064000000000
   Treasury Stock000000000-26,434-29,182-29,364-43,411-45,877000000000
   Other Stockholders Equity -4,500-4,749-6,753-10,133-9,693-10,138-7,861-7,200-8,049-8,358-8,239-6,330-394-138-5,795-5,456-7,277-7,490-7,745-8,353-9,510-9,621-9,599



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue470,252
Cost of Revenue-386,412
Gross Profit83,84083,840
 
Operating Income (+$)
Gross Profit83,840
Operating Expense-430,585
Operating Income39,667-346,745
 
Operating Expense (+$)
Research Development-
Selling General Administrative44,173
Selling And Marketing Expenses-
Operating Expense430,58544,173
 
Net Interest Income (+$)
Interest Income-
Interest Expense-9,152
Net Interest Income-9,152-9,152
 
Pretax Income (+$)
Operating Income39,667
Net Interest Income-9,152
Other Non-Operating Income Expenses-
Income Before Tax (EBT)36,11034,072
EBIT - interestExpense = 32,145
35,618
28,879
Interest Expense9,152
Earnings Before Interest and Taxes (ebit)41,29745,262
Earnings Before Interest and Taxes (ebitda)63,778
 
After tax Income (+$)
Income Before Tax36,110
Tax Provision-15,891
Net Income From Continuing Ops20,21920,219
Net Income19,727
Net Income Applicable To Common Shares19,727
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-1,324
Total Other Income/Expenses Net5,5959,152
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
BIEI.PINK
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BIEI.PINK.

BIEI.PINK Daily Candlestick Chart
BGTTF.OTCQB
2 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of BGTTF.OTCQB.

BGTTF.OTCQB Daily Candlestick Chart
BEG.LSE
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BEG.LSE.

BEG.LSE Daily Candlestick Chart
VINNY.NSE
5 minutes ago

I found you a MACD Bearish Reversal Divergence on the daily chart of VINNY.NSE.

VINNY.NSE Daily Candlestick Chart
BCTF.OTCQB
5 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BCTF.OTCQB.

BCTF.OTCQB Daily Candlestick Chart
BBLG.PINK
8 minutes ago

I found you a RSI Bearish Hidden Divergence on the daily chart of BBLG.PINK.

BBLG.PINK Daily Candlestick Chart
BAR.BR
9 minutes ago

I found you a Death Cross on the daily chart of BAR.BR.

BAR.BR Daily Candlestick Chart
BAESY.PINK
10 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of BAESY.PINK.

BAESY.PINK Daily Candlestick Chart
AXJO.INDX
13 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AXJO.INDX.

AXJO.INDX Daily Candlestick Chart
AXGD.INDX
14 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AXGD.INDX.

AXGD.INDX Daily Candlestick Chart
AXAT.INDX
14 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AXAT.INDX.

AXAT.INDX Daily Candlestick Chart
AXAHY.OTCQX
14 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AXAHY.OTCQX.

AXAHY.OTCQX Daily Candlestick Chart
AW06.INDX
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AW06.INDX.

AW06.INDX Daily Candlestick Chart
AW02.INDX
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AW02.INDX.

AW02.INDX Daily Candlestick Chart
ATF.INDX
19 minutes ago

I found you a Golden Cross on the daily chart of ATF.INDX.

ATF.INDX Daily Candlestick Chart
ASCCY.PINK
20 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ASCCY.PINK.

ASCCY.PINK Daily Candlestick Chart
ARB.LSE
24 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ARB.LSE.

ARB.LSE Daily Candlestick Chart
ARCK.NASDAQ
24 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ARCK.NASDAQ.

ARCK.NASDAQ Daily Candlestick Chart
APRU.PINK
25 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of APRU.PINK.

APRU.PINK Daily Candlestick Chart
AORD.INDX
26 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AORD.INDX.

AORD.INDX Daily Candlestick Chart
AGM.LSE
36 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of AGM.LSE.

AGM.LSE Daily Candlestick Chart
AET.LSE
39 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of AET.LSE.

AET.LSE Daily Candlestick Chart
AEX.INDX
39 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AEX.INDX.

AEX.INDX Daily Candlestick Chart
ACKB.BR
43 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ACKB.BR.

ACKB.BR Daily Candlestick Chart
3SIL.LSE
1 hour ago

I found you a MACD Bearish Reversal Divergence on the daily chart of 3SIL.LSE.

3SIL.LSE Daily Candlestick Chart